Embed presentation
Downloaded 251 times









The document summarizes pyrimidine nucleotide degradation and the salvage pathway. It also describes orotic aciduria, a rare metabolic disorder characterized by orotic acid in urine, anemia, and stunted growth. Orotic aciduria can be caused by deficiencies in enzymes involved in pyrimidine synthesis or a defect in the urea cycle enzyme ornithine transcarbamoylase, which diverts carbamoyl phosphate to increased orotic acid synthesis. The condition can be treated by supplementing with cytidine or uridine.
Discusses the reactions of pyrimidine nucleotides leading to nitrogenous bases and conversion to soluble products, as well as the salvage pathway for nucleotides.
Describes orotic aciduria, its metabolic disorder characteristics, symptoms, enzyme deficiencies, and treatment options with cytidine or uridine.
Explains secondary orotic aciduria due to ornithine transcarbamoylase defect, the accumulation of carbamoyl phosphate, and its effects on orotic acid synthesis.
Lists references including textbooks by U Satyanarayana and DM Vasudevan for further reading on biochemistry.








